Bio Plus Co

Bio Plus Co Working Capital

The Working Capital of Bio Plus Co (099430.KQ) as of Oct 21, 2026 is 15.01 B KRW. In the previous year, Working Capital was 12.96 B KRW — a change of 15.87% (higher).

Working Capital

15.01 BKRW

YoY

15.87%

Last updated:

Working Capital of Bio Plus Co is 2025 15.01 B KRW. Working Capital of Bio Plus Co was 2024 12.96 B KRW. It decreases by 15.87% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bio Plus Co Stock analysis

What does Bio Plus Co do? BioPlus Co., Ltd. generates revenue through the manufacturing and sale of dermal fillers, primarily hyaluronic acid fillers for temporary facial wrinkle improvement. The company also produces and sells anti-adhesion agents to prevent surgical adhesions, biomaterials for joint tissue repair, and other tissue restoration products. These products are supplied to medical professionals and healthcare facilities requiring cosmetic and surgical solutions. The firm targets the medical and cosmetic sectors, focusing on tissue restoration applications for both aesthetic and functional needs. The company's product portfolio includes biomaterials for tissue restoration, specifically designed for temporary facial wrinkle correction, anti-adhesion solutions for surgical sites, and joint tissue repair materials. These offerings cater to healthcare providers seeking advanced biomaterials for patient care. BioPlus Co., Ltd. serves the medical industry by providing specialized products that address both cosmetic enhancement and post-surgical recovery requirements. BioPlus Co., Ltd. operates within the biomaterials sector, focusing on dermal fillers and tissue repair solutions. Its products are utilized by medical practitioners for facial aesthetics and surgical applications. The company's revenue streams are derived from direct sales of these biomaterial products to healthcare institutions and professionals in the medical field. Bio Plus Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio Plus Co stock

Working Capital of Bio Plus Co is 15.01 B KRW in 2025.

Working Capital of Bio Plus Co changed from 12.96 B KRW to 15.01 B KRW, representing a 15.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Bio Plus Co since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Bio Plus Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Bio Plus Co

All Key Metrics — Bio Plus Co